Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug powerhouse and has become one of the world’s most successful female ...

Herceptin Global Market Report 2025 The Business Research Company's Herceptin Global Market Report 2025 – Market Size, Trends, And Global F ...

MANILA, Philippines — Semirara Mining and Power Corp. (SMPC) of tycoon Isidro Consunji has secured the key environmental clearance to proceed with its planned P291-billion coal mine expansion ...

Semirara Mining obtained the go-signal from the Department of Environment and Natural Resources for its P291-billion coal mine expansion.

Merck's (NYSE:MRK) top-selling drug – Keytruda's – impressive recent growth tells a compelling story, but it's one with a predictable ending. The pharmaceutical giant's remarkable performance ...

CHICAGO — Second-line trastuzumab deruxtecan-nxki significantly extended OS compared with paclitaxel plus ramucirumab for patients with advanced gastric cancers previously treated with ...

Roche, on the other hand, will provide Herceptin 600 mg, along with other innovations for HER2-positive breast cancer, to ensure access for all eligible SHA beneficiaries.

Roche's Perjeta, Herceptin and chemotherapy regimen cut the risk of death by 17% in patients with early-stage HER2-positive breast cancer over 10 years.

Trastuzumab Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each ...

Herceptin with chemotherapy improved OS and PFS in HER2-positive gastric cancers, but benefits decreased after chemotherapy regimen changes. Major pathological response rates were higher with ...